FDA issued a Warning Letter to Dexcowin Co. Ltd. on 2/20/2018 as a result of this inspection.
483 Dexcowin Aug 2017

483 Dexcowin Aug 2017

$119 - Not in Stock

FDA investigators audited the Dexcowin - Gansan-dong, Geumcheon-gu, Korea (the Republic of) facility and issued inspectional observations (via FDA 483) on 31 Aug 2017.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 31 Aug 2017
  • Location: Gansan-dong, Geumcheon-gu, Korea (the Republic of)
  • FEI: 3007065358

Pre-Order Not Available